Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Telus
TU
$15.4B
| $2.44M | ﹤0.01% |
152,119
+137,616
| +949% | +$2.41M |
|
2377
Apogee Therapeutics
APGE
$10.2B
| $2.44M | ﹤0.01% |
36,646
+2,590
| +8% | +$113K |
|
2378
Constellium
CSTM
$4.05B
| $2.43M | ﹤0.01% |
110,020
-93,129
| -46% | -$1.8M |
|
2379
Syndax Pharmaceuticals
SNDX
$1.79B
| $2.43M | ﹤0.01% |
102,172
-153,705
| -60% | -$3.43M |
|
|
IAS
2380
DELISTED
Integral Ad Science
IAS
| $2.42M | ﹤0.01% |
243,061
+53,288
| +28% | +$711K |
|
|
RCM
2381
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.41M | ﹤0.01% |
187,456
-21,932
| -10% | -$255K |
|
2382
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $2.41M | ﹤0.01% |
74,900
-3,400
| -4% | -$108K |
|
2383
iPath Select MLP ETN
ATMP
$625M
| $2.41M | ﹤0.01% |
100,000
| – | – |
|
2384
Arbor Realty Trust
ABR
$989M
| $2.41M | ﹤0.01% |
182,096
-135,427
| -43% | -$1.82M |
|
2385
CALL
Madrigal Pharmaceuticals
MDGL
$11.8B
| $2.4M | ﹤0.01% |
+9,000
| New | +$2.12M |
|
2386
City Holding Co
CHCO
$2.04B
| $2.4M | ﹤0.01% |
23,049
-9,086
| -28% | -$937K |
|
2387
PennyMac Financial
PFSI
$4.01B
| $2.4M | ﹤0.01% |
26,349
-18,533
| -41% | -$1.62M |
|
|
RC
2388
Ready Capital
RC
$306M
| $2.4M | ﹤0.01% |
262,501
-218,341
| -45% | -$2.02M |
|
2389
CALL
CSX Corp
CSX
$94.2B
| $2.39M | ﹤0.01% |
64,600
+58,400
| +942% | +$2.13M |
|
|
NGD
2390
DELISTED
New Gold Inc
NGD
| $2.39M | ﹤0.01% |
1,408,053
+1,183,879
| +528% | +$1.62M |
|
2391
State Street SPDR S&P Dividend ETF
SDY
$23.9B
| $2.39M | ﹤0.01% |
+18,191
| New | +$2.28M |
|
2392
Global E Online
GLBE
$7.02B
| $2.39M | ﹤0.01% |
65,628
-36,489
| -36% | -$1.35M |
|
2393
Dyne Therapeutics
DYN
$4.73B
| $2.38M | ﹤0.01% |
83,972
-69,379
| -45% | -$1.57M |
|
2394
Fate Therapeutics
FATE
$296M
| $2.38M | ﹤0.01% |
324,243
-35,132
| -10% | -$217K |
|
2395
TG Therapeutics
TGTX
$7.6B
| $2.38M | ﹤0.01% |
156,380
-271,633
| -63% | -$4.33M |
|
2396
Shift4
FOUR
$3.17B
| $2.38M | ﹤0.01% |
35,976
-2,706
| -7% | -$204K |
|
|
MPT
2397
PUT
Medical Properties Trust
MPT
$2.79B
| $2.37M | ﹤0.01% |
505,000
+458,700
| +991% | +$1.76M |
|
2398
PUT
Baidu
BIDU
$37.2B
| $2.37M | ﹤0.01% |
22,500
-45,000
| -67% | -$4.79M |
|
2399
Hims & Hers Health
HIMS
$7.2B
| $2.37M | ﹤0.01% |
152,909
-181,918
| -54% | -$2.05M |
|
|
NUVL
2400
DELISTED
Nuvalent
NUVL
| $2.36M | ﹤0.01% |
31,450
-56,655
| -64% | -$4.51M |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.